Basu Saurav, Garg Suneela, Sharma Nandini, Singh M Meghachandra, Garg Sandeep, Asaria Miqdad
Department of Community Medicine, Maulana Azad Medical College, New Delhi, India.
Department of Medicine, Maulana Azad Medical College, New Delhi, India.
Perspect Clin Res. 2020 Apr-Jun;11(2):86-91. doi: 10.4103/picr.PICR_169_18. Epub 2020 May 6.
To assess the determinants of out-of-pocket (OOP) expenses on diabetes-related treatment incurred in patients attending outpatient clinics in a tertiary care hospital in Delhi, India.
A cross-sectional analysis of baseline data from a quasi-experimental study was conducted over 8 months in 2016 in a major tertiary care hospital in Delhi.
The study included 375 diabetes patients up to 65 years of age on treatment for at least a year without significant complications. Data were collected through a patient interview schedule.
Of the previous six scheduled appointments, at least two missed appointments were seen in 267 (71.2%) patients. The average patient's OOP expenditure on diabetes-related medicines was ₹63.5 a month, a similar amount was spent on traveling to and from health facilities. Sixty-four (17.1%) patients took antidiabetic medication for <85% of the days in the previous 3 months.
There exists a high burden of missed clinic appointments among diabetes patients in tertiary care government health settings in India. This appears to be related to the high cost in terms of both time and money involved in attending appointments for the modest benefit of a dispensation of a 15-day drug refill. Health policy measures focused on strengthening medication coverage need to explore the balance of costs and benefits when determining the frequency of clinical appointments in these settings.
评估印度德里一家三级护理医院门诊患者糖尿病相关治疗的自付费用的决定因素。
2016年在德里一家主要的三级护理医院对一项准实验研究的基线数据进行了为期8个月的横断面分析。
该研究纳入了375名65岁及以下接受治疗至少一年且无重大并发症的糖尿病患者。通过患者访谈问卷收集数据。
在之前的六次预约就诊中,267名(71.2%)患者至少有两次未按时就诊。患者每月在糖尿病相关药物上的自付费用平均为63.5卢比,往返医疗机构的费用也大致相同。在过去3个月中,64名(17.1%)患者服用抗糖尿病药物的天数不足85%。
在印度政府三级护理医疗机构中,糖尿病患者错过门诊预约的负担很重。这似乎与为了获得15天药物补充的适度益处而就诊所涉及的时间和金钱成本高昂有关。在确定这些机构的临床预约频率时,侧重于加强药物覆盖的卫生政策措施需要探索成本与效益之间的平衡。